Skip to main content
. 2024 Mar 15;24:109. doi: 10.1186/s12876-024-03190-2

Table 5.

Analysis of the correlation between the study variables and MAFLD from NHANES 2007–2016

Characteristic OR1 95% CI1 p-value
Model1
AGTR 0.31 0.29, 0.33  < 0.001
AIP
 Q1(≤ -0.2824)
 Q2(-0.2824, -0.0687) 2.66 2.17, 3.26  < 0.001
 Q3(-0.0687,0.1634) 6.16 5.08, 7.46  < 0.001
 Q4(> 0.1634) 16.7 13.3, 21.0  < 0.001
Model2
AGTR 0.30 0.28, 0.32  < 0.001
AIP
 Q1(≤ -0.2824)
 Q2(-0.2824, -0.0687) 2.56 2.11, 3.12  < 0.001
 Q3(-0.0687,0.1634) 5.88 4.86, 7.11  < 0.001
 Q4(> 0.1634) 16.3 13.0, 20.5  < 0.001
Model3
AGTR 0.30 0.27, 0.33  < 0.001
AIP
 Q1(≤ -0.2824)
 Q2(-0.2824, -0.0687) 1.81 1.35, 2.44  < 0.001
 Q3(-0.0687,0.1634) 3.32 2.61, 4.21  < 0.001
 Q4(> 0.1634) 7.27 5.47, 9.65  < 0.001

Model1 No variables were adjusted

Model2 Adjusted for age, gender, race, and income poverty ratio

Model3 Adjusted for BMI, physical activity, diabetes mellitus, alkaline phosphatase, mercury, cadmium, transaminases, smoking, drinking, protein intake, vitamin C and potential confounders of LDL on a previous basis based on model2

AGTR albumin to glutamyl transpeptidase ratio, AIP plasma atherogenicity index

1OR Odds Ratio, CI Confidence Interval